← Leaderboards
Jordan T Shin
Massachusetts General Hospital
$688,230
Attributed
$688,230
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $138K · FY2008–12$200K$150K$100K$50K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$688,230 · 1
By mechanism
K08$688,230 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Paul B Yu$13,557,400
- Kenneth D Bloch$14,282,889
- Ahmed A Tawakol$9,912,063
- Charles A Hales$9,896,268
- Bradley T Hyman$51,936,441
Others in their field
Top investigators on “Cessation Of Life”
- David R. Weir · University Of Michigan At Ann Arbor$345,522,974
- John M Lachin · George Washington University$134,302,892
- David M Nathan · Massachusetts Institute Of Technology$127,791,564
- Judith S Hochman · New York University School Of Medicine$112,898,313
- Jeffrey H Samet · Boston University Medical Campus$91,739,367
- Judith S. Currier · University Of California Los Angeles$85,330,415
Research focus
Cessation Of LifeDefectAngiogenesisAdultAdvisory CommitteesArteriovenous MalformationAttenuatedBaseAnimal ModelBloodAnimalsBlood VesselsBmpr2 GeneBone Morphogenetic Protein 2Bone Morphogenetic Protein ReceptorsBone Morphogenetic ProteinsCardiovascular SystemCareerBiologyCell BehaviorCellsCell SurfaceBlood CirculationDesign
Grant awards (5)
The role of BMPR2 in blood vesel development and patterning in vivo$137,970
K08 · FY2012 · HL · contact PI
The role of BMPR2 in blood vesel development and patterning in vivo$137,970
K08 · FY2011 · HL · contact PI
The role of BMPR2 in blood vesel development and patterning in vivo$137,970
K08 · FY2010 · HL · contact PI
The role of BMPR2 in blood vesel development and patterning in vivo$137,565
K08 · FY2009 · HL · contact PI
The role of BMPR2 in blood vesel development and patterning in vivo$136,755
K08 · FY2008 · HL · contact PI